Cargando…

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence studies bridge the gap left from case detection, to estimate the true burden of the COVID-19 pandemic. While multiple anti-SARS-CoV-2 immunoassays are available, no gold standard exists. METHODS: This serial cros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saeed, Sahar, O’Brien, Sheila F., Abe, Kento, Yi, Qi-Long, Rathod, Bhavisha, Wang, Jenny, Fazel-Zarandi, Mahya, Tuite, Ashleigh, Fisman, David, Wood, Heidi, Colwill, Karen, Gingras, Anne-Claude, Drews, Steven J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459951/ https://www.ncbi.nlm.nih.gov/pubmed/34555095 http://dx.doi.org/10.1371/journal.pone.0257743

Ejemplares similares

Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays
por: Tuite, Ashleigh R., et al.
Publicado: (2022)

Resistance of SARS‐CoV‐2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020
por: Drews, Steven J., et al.
Publicado: (2021)

A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021
por: Abe, Kento T., et al.
Publicado: (2022)

Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021
por: Lin, Yi-Chan J., et al.
Publicado: (2023)

SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History
por: Drews, Steven J., et al.
Publicado: (2022)

Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses
por: Lin, Yi-Chan J., et al.
Publicado: (2022)

Tracking SARS-CoV-2 seroprevalence among Canadian blood donors
por: Saeed, Sahar, et al.
Publicado: (2022)

A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination
por: Colwill, Karen, et al.
Publicado: (2022)

Age-Specific Changes in Virulence Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern
por: Fisman, David N, et al.
Publicado: (2022)

SARS-CoV-2 Seroprevalence in the Vaccine Era: The Canadian Blood Services Serosurvey January to November 2021
por: O'Brien, Sheila, et al.
Publicado: (2023)

Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada
por: Fisman, David N., et al.
Publicado: (2021)

SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron
por: O’Brien, Sheila F., et al.
Publicado: (2022)

Projected Impact of Vaccination Timing and Dose Availability on the Course of the 2014 West African Ebola Epidemic
por: Fisman, David, et al.
Publicado: (2014)

Impact of population mixing between vaccinated and unvaccinated subpopulations on infectious disease dynamics: implications for SARS-CoV-2 transmission
por: Fisman, David N., et al.
Publicado: (2022)

Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era
por: Reedman, Cassandra N., et al.
Publicado: (2022)

Estimation of the Health Impact and Cost-Effectiveness of Influenza Vaccination with Enhanced Effectiveness in Canada
por: Fisman, David N., et al.
Publicado: (2011)

Early Epidemic Dynamics of the West African 2014 Ebola Outbreak: Estimates Derived with a Simple Two-Parameter Model
por: Fisman, David, et al.
Publicado: (2014)

The epidemiology of MERS-CoV
por: Fisman, David N, et al.
Publicado: (2014)

Asymptomatic infection is the pandemic’s dark matter
por: Fisman, David N., et al.
Publicado: (2021)

The authors respond to criticisms of their model parameters
por: Fisman, David, et al.
Publicado: (2022)

Estimation of the Underlying Burden of Pertussis in Adolescents and Adults in Southern Ontario, Canada
por: McGirr, Ashleigh A., et al.
Publicado: (2013)

Screen more or screen more often? Using mathematical models to inform syphilis control strategies
por: Tuite, Ashleigh R, et al.
Publicado: (2013)

Relative Virulence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Vaccinated and Unvaccinated Individuals Hospitalized With SARS-CoV-2
por: Grima, Alicia A, et al.
Publicado: (2022)

Kindlin2 enables EphB/ephrinB bi-directional signaling to support vascular development
por: Li, Wenqing, et al.
Publicado: (2022)

A simple protein-based surrogate neutralization assay for SARS-CoV-2
por: Abe, Kento T., et al.
Publicado: (2020)

Severity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Pregnancy in Ontario: A Matched Cohort Analysis
por: Murison, Kiera R, et al.
Publicado: (2022)

Sporadic SARS-CoV-2 cases at the neighbourhood level in Toronto, Ontario, 2020: a spatial analysis of the early pandemic period
por: Obress, Lindsay, et al.
Publicado: (2022)

The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020–2023
por: Murphy, Tanya J., et al.
Publicado: (2023)

Cost-Effectiveness of Enhanced Syphilis Screening among HIV-Positive Men Who Have Sex with Men: A Microsimulation Model
por: Tuite, Ashleigh R., et al.
Publicado: (2014)

Historical Epidemiology of the Second Cholera Pandemic: Relevance to Present Day Disease Dynamics
por: Chan, Christina H., et al.
Publicado: (2013)

Estimation of COVID-19 outbreak size in Italy
por: Tuite, Ashleigh R, et al.
Publicado: (2020)

Bidirectional impact of imperfect mask use on reproduction number of COVID-19: A next generation matrix approach()
por: Fisman, David N., et al.
Publicado: (2020)

Seasonal Influenza Vaccine Allocation in the Canadian Population during a Pandemic
por: Tuite, Ashleigh, et al.
Publicado: (2009)

An IDEA for Short Term Outbreak Projection: Nearcasting Using the Basic Reproduction Number
por: Fisman, David N., et al.
Publicado: (2013)

Effects of large-scale oceanic phenomena on non-cholera vibriosis incidence in the United States: implications for climate change
por: Logar-Henderson, Chloë, et al.
Publicado: (2019)

Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of Health
por: O’Brien, Sheila F., et al.
Publicado: (2023)

Optimal Pandemic Influenza Vaccine Allocation Strategies for the Canadian Population
por: Tuite, Ashleigh R., et al.
Publicado: (2010)

Assessment of SARS-CoV-2 Seropositivity During the First and Second Viral Waves in 2020 and 2021 Among Canadian Adults
por: Tang, Xuyang, et al.
Publicado: (2022)

Seasonal Influenza Forecasting in Real Time Using the Incidence Decay With Exponential Adjustment Model
por: Nasserie, Tahmina, et al.
Publicado: (2017)

Geographical Variability in the Likelihood of Bloodstream Infections Due to Gram-Negative Bacteria: Correlation with Proximity to the Equator and Health Care Expenditure
por: Fisman, David, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_53gp72cpbp4rq016vuhit5ea9q